Recital 1, Regulation (EU) 2025/2086

In forcesince 17 Oct 2025

Pursuant to Article 7(4) of Regulation (EU) 2021/2282, the Commission, after seeking a recommendation from the Member State Coordination Group on Health Technology Assessment established under Article 3 of that Regulation (‘the Coordination Group’), is to adopt a decision, by means of an implementing act and at least every two years selecting for joint clinical assessment medical devices and in vitro diagnostic medical devices (‘medical devices’). The Commission is to select those devices from the medical devices for which the relevant expert panels designated in accordance with Article 106(1) of Regulation (EU) 2017/745 of the European Parliament and of the Council [Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (OJ L 117, 5.5.2017, p. 1, ELI: http://data.europa.eu/eli/reg/2017/745/oj).] (‘the expert panels’) provided a scientific opinion or their views.